 abdominal disorders present limited number overlapping symptoms. Blood tests routinely available use diagnosis investigation tends require complex imaging procedures endoscopy biopsy. invasive patient, may associated morbidity mortality considerable resource implications. Biochemical tests single sample faeces therefore valuable alternative. Measurement faecal calprotectin shown role diagnosis inflammatory bowel disease monitoring. Lactoferrin also benefit used way. Faecal elastase demonstrated use diagnosis pancreatic insufficiency. number faecal markers explored colorectal cancer. Faecal occult blood testing used population screening, metabolomic marker tumour, M2-pyruvate kinase, potential use diagnosis screening. DNA testing advantages colorectal cancer exact applications tests require evaluation.